Fluigent, Inc.
Chelmsford, MA
- UEI
- NDHRU4ZLGJ79
- CAGE
- 7PBY7
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
SQK4VM796643
-
Parent
SQK4VM796643
- SAM.gov registration date
- Physical address
- 73 Princeton St, North Chelmsford, MA 01863, USA
- Website
- fluigent.com
- Founded
- 2005
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $21,710 |
| FY2024 | $100,342 |
| FY2023 | $40,263 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Fluigent, Inc. is a foreign-owned, for-profit organization specializing in advanced microfluidic solutions and fluid handling technologies. Registered in SAM.gov since August 5, 2016, the company is based in North Chelmsford, Massachusetts, and focuses on providing cutting-edge scientific research equipment primarily to federal agencies in the biomedical and medical research sectors. The company's core business involves designing and manufacturing sophisticated microfluidic systems, pressure generators, and automated perfusion systems that support complex scientific research and experimentation across various disciplines.
Fluigent, Inc. has been awarded numerous federal contracts from agencies such as the National Institutes of Health (NIH), Food and Drug Administration (FDA), Department of Agriculture (USDA), Department of Veterans Affairs, and the National Cancer Institute. These contracts, ranging from $10,520 to $42,455, involve the procurement of specialized microfluidic equipment for research purposes, including organ-on-a-chip studies, spatial omics research, synaptic transmission investigations, and COVID-19 related scientific initiatives. Some contracts were set aside for small businesses, while others were awarded without specific set-aside designations. The equipment supplied includes ARIA Automated Perfusion Systems, microfluidic flow controllers, high-pressure reagent reservoirs, fluid flow sensors, and other precision fluid handling technologies. These contracts demonstrate Fluigent's critical role in supporting federal research efforts across multiple scientific domains, with a particular emphasis on advanced biomedical and medical research applications.
Quick answers
Is Fluigent, Inc. registered in SAM.gov?
Yes. Fluigent, Inc.'s SAM.gov registration is active through May 28, 2027.
How much has Fluigent, Inc. received in federal contracts?
Federal contracts obligated $21,710 to Fluigent, Inc. in fiscal year 2025 and $162,315 in fiscal years 2023 through 2027.
What is Fluigent, Inc.'s most recent federal award?
Fluigent, Inc.'s most recent federal contract award is Aria automated perfusion system (75N91025P00342), from National Cancer Institute (NIH), on March 26, 2025.
On GovTribe
See Fluigent, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors